2024. Molecular Docking and ADMET Profiling of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin from Dalbergia sissoo: In Silico Prediction in Antidiabetic Potential. International Journal of Pharmaceutical Sciences and Drug Research. 16, 5 (Sep. 2024), 841–854. DOI:https://doi.org/10.25004/IJPSDR.2024.160512.